Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IDEXX Laboratories, Inc. - Common Stock (NQ:IDXX)

672.04 UNCHANGED
Delayed Quote Updated: 4:00 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IDEXX Laboratories, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Market Today: Marvell’s $115 Billion Bet on Lumentum Backfires as Chip Stocks Drag the Nasdaq Lower ↗
Via Chartmill
S&P 500 Top Movers Today: IDXX Jumps 20.39%, LITE Drops 18.23% ↗
Via Chartmill
Topics Stocks
S&P 500 Unusual Volume Movers for Nov. 2, 2026 ↗
Via Chartmill
Topics Stocks
S&P 500 Top Movers for Nov. 2, 2026: IDXX Gains 19.59%, LITE Falls 13.94% ↗
Via Chartmill
Topics Stocks
IDEXX Laboratories (NASDAQ:IDXX) Q3 EPS Beat and Raised Guidance Fuel Relief Rally Despite In-Line Revenue ↗
Via Chartmill
IDEXX Laboratories (NASDAQ:IDXX) Shares Rise on Q2 Earnings Beat and Improved Outlook ↗
Via Chartmill
Topics Earnings
News headline image
IDEXX Sales Rise 10% as Margin Outlook Slips: Rapid Earnings Reaction ↗
IDEXX raised its 2026 earnings forecast, but it also trimmed its margin outlook. Here’s what is really behind the raise, and why testing demand isn’t the reason. 
Via The Motley Fool
News headline image
IDEXX (IDXX) Q3 2026 Earnings Call Transcript ↗
Diagnostics revenue surged 11% as premium instrument placements expanded globally. 
Via The Motley Fool
Topics Earnings
News headline image
IDEXX Laboratories Q3 Earnings Call Highlights ↗
IDEXX Laboratories (NASDAQ:IDXX) reported third-quarter 2026 results marked by organic revenue growth, higher diagnostic utilization and expanded placement of its premium instruments, while raising its... 
Via MarketBeat
Topics ETFs Earnings
S&P 500 Opening Gap Movers for November 2, 2026 ↗
Via Chartmill
Topics Stocks
US Gap Movers: Top Gap-Up and Gap-Down Stocks in Today's Session ↗
Via Chartmill
S&P 500 Premarket Movers Nov. 2, 2026: IDEXX and Fox Gain, Lumentum and T-Mobile Fall ↗
Via Chartmill
Topics Stocks
News headline image
IDEXX Laboratories Announces Third Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
S&P 500 Top Movers Today: HONA Tops Gainers, TWLO Tops Decliners ↗
Via Chartmill
Topics Stocks
News headline image
IDEXX Laboratories to Release 2026 Third Quarter Financial Results
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets ↗
IDEXX Laboratories (NASDAQ:IDXX) executives highlighted the company’s diagnostic innovation pipeline, recurring-revenue growth and commercial investments during the Morgan Stanley Global Healthcare... 
Via MarketBeat
Topics ETFs
News headline image
IDEXX Highlights Diagnostics Growth Drivers, Cancer Testing at Morgan Stanley Conference ↗
IDEXX Laboratories (NASDAQ:IDXX) executives reiterated the company’s long-term growth framework at the Morgan Stanley Global Healthcare Conference, citing demand for veterinary diagnostics, product... 
Via MarketBeat
Topics ETFs
News headline image
IDEXX Laboratories Acquires CoVetAI to Advance Veterinary Workflow Intelligence
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
Insider Alert: IDEXX Director Lawrence Kingsley Sells $1.2 Million of Stock ↗
Kingsley exercised options at $114.17 per share before immediately selling at $532.08, capturing a significant gain. His direct stake remains at 9,568 shares worth $5.12 million. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX Laboratories Targets $45B Pet Diagnostics Opportunity With AI, Cancer Tests ↗
IDEXX Laboratories (NASDAQ:IDXX) outlined an innovation-led growth strategy at its 2026 Investor Day, highlighting a $45 billion global companion-animal testing opportunity, expanded commercial... 
Via MarketBeat
Topics Artificial Intelligence ETFs
News headline image
IDEXX (IDXX) Q2 2026 Earnings Call Transcript ↗
Diagnostic innovations fuel 10% CAG recurring revenue growth despite wellness visit pressure. 
Via The Motley Fool
Topics Earnings
News headline image
IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX Laboratories Q2 Earnings Call Highlights ↗
IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter 2026 revenue growth of approximately 10% on a reported basis and 9% organically, driven by companion animal diagnostics, water and livestock,... 
Via MarketBeat
Topics ETFs Earnings
News headline image
IDEXX Laboratories Q2 2026 Earnings Call Transcript ↗
IDEXX Laboratories (NASDAQ:IDXX) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought... 
Via Benzinga
Topics Earnings
News headline image
IDEXX Laboratories Announces Second Quarter Results
From IDEXX Laboratories, Inc.
Via Business Wire
News headline image
IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals
From IDEXX Laboratories, Inc.
Via Business Wire
Which S&P500 stocks are moving on Wednesday? ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
These 3 Water ETFs Could be Quiet Winners From Infrastructure Spending ↗
As data centers strain water systems, FIW, PHO, and CGW offer investors ETF-based access to water utilities, infrastructure, and equipment firms, each with distinct fees and concentration. 
Via MarketBeat
Topics Artificial Intelligence ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.